Arnold & Porter Kaye Scholer
Firm overview:
Arnold & Porter Kaye Scholer is a well-regarded full-service firm with ten US offices, plus locations in London, Amsterdam, Brussels, Seoul and Shanghai.
Within its Intellectual Property practice group, the firm has a strong offering in patent litigation, post-grant proceedings, and patent prosecution. Representative non-contentious work includes patent prosecution for Johnson & Johnson, Merck, Bayer and Pfizer.
Arnold & Porter’s team of more than 70 patent litigators takes on complex, high-stakes cases for leading companies, particularly in the life sciences and technology sectors. More than half of its patent attorneys hold engineering and scientific degrees, and they have litigated disputes before the Patent Trial and Appeal Board (PTAB), the International Trade Commission (ITC) and federal courts across the US.
Some of the team’s high-profile successes include representing Nike in patent matters; defending Adobe in relation to various technologies as well as protecting its IP rights; obtaining a $35 million jury verdict and $180 million global settlement agreement for Boston Scientific; and representing Samsung in patent litigation against a university.
Team overview:
Washington, DC partner Matthew Wolf has been lead trial counsel in some of the most significant patent cases involving life sciences, technology and consumer goods companies—including Amgen v Sanofi/Regeneron—and is renowned for his courtroom skills.
Partner Daniel DiNapoli, who is recognised as a WIPR Leader and based in New York, concentrates his practice in patent, trade secret, and unfair competition litigation and counselling. His notable representations include ANDA litigation involving Pfizer’s blockbuster drugs Viagra and Celebrex.
Additions to the team over the past year include patent litigators David Sheikh and Brian Haan, founding partners of Chicago IP firm Lee Sheikh & Haan which has now ceased operations.
Key matters:
- Omnitracs v Motive
Arnold & Porter represented artificial intelligence (AI)-powered integrated operations platform Motive in a patent infringement lawsuit brought by Omnitracs in California.
A jury determined that Motive did not infringe any of Omnitracs’ four asserted patents, following an eight-day trial.
Arnold & Porter partner Brent Ray led the trial team.
Clients:
Clients: Motive
